This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yang, L.-Y. Articles by Drewinko, B. Search for Related Content PubMed PubMed Citation Articles by Yang, L.-Y. Articles by Drewinko, B.

Cytotoxic Efficacy of Reconstituted and Stored Antitumor Agents¹

Department of Laboratory Medicine, University of Texas System Cancer Center, M. D. Anderson Hospital and Tumor Institute at Houston, Houston, Texas 77030

The stability of the cell-killing efficacy of 10 antitumor drugs stored at different temperatures and concentrations was evaluated on an established human colon carcinoma cell line using the colony formation technique. Drugs were reconstituted in the appropriate solvent, further diluted in 0.9% NaCl solution to obtain the desired storage concentration, and stored at 4 °C, -20 °C, and -70 °C for periods of up to 3 weeks. Cytotoxic efficacy was tested weekly by exposing the cells to the final drug dilution for 1 h at 37 °C.

Stability of cytotoxic potency depended on the particular drug, and the duration, concentration, and temperature of storage but, in general, most drugs remained efficacious only within limited periods of time (at most, 2 weeks). These results suggest that the conditions of drug storage following reconstitution are critical factors with respect to lethal efficacy. Therefore, analysis of in vitro cytotoxic efficacy can be meaningful only when storage conditions are specified in order to avoid false-negative results in the human tumor clonogenic assay.

¹ Supported by Grant CA 23272 from the National Cancer Institute.

² To whom requests for reprints should be addressed, at Chief, Section of Laboratory, Hematology Department of Laboratory Medicine/Box #73 UTSCC-M. D. Anderson Hospital and Tumor Institute, 6723 Bertner Avenue, Houston, TX 77030.

Received 8/27/84. Revised 12/11/84. Accepted 12/27/84.

This article has been cited by other articles:

				R. T. Dorr and J. D. Liddil Stability of mitomycin C in different infusion fluids: Compatibility with heparin and glucocorticosteroids Journal of Oncology Pharmacy Practice, January 1, 1995; 1(3): 19 - 24. [Abstract] [PDF]